Dr Kneeland Youngblood - Jun 10, 2023 Form 4 Insider Report for Light & Wonder, Inc. (LNW)

Role
Director
Signature
/s/ James Sottile, attorney-in-fact for Dr. Kneeland Youngblood
Stock symbol
LNW
Transactions as of
Jun 10, 2023
Transactions value $
$0
Form type
4
Date filed
6/12/2023, 07:00 PM
Previous filing
Jun 9, 2023
Next filing
Jan 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LNW Common Stock Options Exercise $0 +2.09K +12.63% $0.00 18.7K Jun 10, 2023 Direct
transaction LNW Common Stock Options Exercise $0 +1.93K +10.33% $0.00 20.6K Jun 12, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LNW Restricted Stock Units Options Exercise $0 -2.09K -50% $0.00 2.09K Jun 10, 2023 Common Stock 2.09K Direct F1
transaction LNW Restricted Stock Units Options Exercise $0 -1.93K -100% $0.00* 0 Jun 12, 2023 Common Stock 1.93K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents vesting of one-fourth of restricted stock units granted on June 10, 2020. The balance of the award is scheduled to vest on June 10, 2024. Each unit converts into a share of common stock on a one-for-one basis.
F2 Represents vesting of one-fourth of restricted stock units granted on June 12, 2019. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis.